We are live on
!
Find out more
SA
Sovran Advisors Portfolio holdings
AUM
$1.34B
1-Year Est. Return
21.63%
This Fund
S&P 500
This Quarter
Est. Return
-2.44%
1 Year Est. Return
+21.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$770M
AUM Growth
+$68.8M
(+9.8%)
Cap. Flow
+$130M
Cap. Flow
% of AUM
16.87%
Top 10 Holdings %
Top 10 Hldgs %
19.85%
Holding
481
New
73
Increased
256
Reduced
119
Closed
26
Avg Time Held
0.8
quarters
Top 10 Avg Time Held
0.8
quarters
Top 20 Avg Time Held
0.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$7.21M |
| 2 |
Apple
AAPL
|
+$6.33M |
| 3 |
Ionis Pharmaceuticals
IONS
|
+$5.14M |
| 4 |
Microsoft
MSFT
|
+$5M |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Dynamic Income Fund
PDI
|
+$2.67M |
| 2 |
Johnson & Johnson
JNJ
|
+$2.63M |
| 3 |
Celldex Therapeutics
CLDX
|
+$2.6M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$2.6M |
| 5 |
iShares MSCI EAFE Growth ETF
EFG
|
+$2.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 72.84% |
| 2 | Technology | 9.26% |
| 3 | Healthcare | 4.68% |
| 4 | Consumer Discretionary | 3.53% |
| 5 | Financials | 2.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Accenture
ACN
$131B
| $1.23M | 0.16% |
4,362
+1,472
| +51% | +$520K |
2024 Q4
1 quarter
|
|
152
FS KKR Capital
FSK
$2.96B
| $1.22M | 0.16% |
62,459
+49,433
| +379% | +$1.11M |
2024 Q4
1 quarter
|
|
153
Franklin Senior Loan ETF
FLBL
$801M
| $1.22M | 0.16% |
51,728
+39,568
| +325% | +$959K |
2024 Q4
1 quarter
|
|
154
ExxonMobil
XOM
$716B
| $1.22M | 0.16% |
11,396
-1,242
| -10% | -$137K |
2024 Q4
1 quarter
|
|
155
Palo Alto Networks
PANW
$325B
| $1.16M | 0.15% |
6,923
+1,984
| +40% | +$367K |
2024 Q4
1 quarter
|
|
156
Synchrony
SYF
$23.9B
| $1.14M | 0.15% |
23,710
+838
| +4% | +$51.8K |
2024 Q4
1 quarter
|
|
157
iShares Core Dividend ETF
DIVB
$2.05B
| $1.12M | 0.14% |
24,815
+250
| +1% | +$12.3K |
2024 Q4
1 quarter
|
|
158
Invesco Water Resources ETF
PHO
$1.92B
| $1.1M | 0.14% |
17,653
+3,329
| +23% | +$222K |
2024 Q4
1 quarter
|
|
159
Goldman Sachs
GS
$260B
| $1.1M | 0.14% |
2,150
+1,615
| +302% | +$972K |
2024 Q4
1 quarter
|
|
160
Abbott
ABT
$178B
| $1.08M | 0.14% |
8,279
+1,583
| +24% | +$201K |
2024 Q4
1 quarter
|
|
161
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.6B
| $1.08M | 0.14% |
4,620
+268
| +6% | +$69.7K |
2024 Q4
1 quarter
|
|
162
HCA Healthcare
HCA
$99.8B
| $1.08M | 0.14% |
3,218
-18
| -0.6% | -$5.79K |
2024 Q4
1 quarter
|
|
163
TSMC
TSM
$2.31T
| $1.06M | 0.14% |
6,988
+3,398
| +95% | +$660K |
2024 Q4
1 quarter
|
|
164
Adobe
ADBE
$92B
| $1.06M | 0.14% |
3,034
+1,357
| +81% | +$582K |
2024 Q4
1 quarter
|
|
165
DoubleLine Income Solutions Fund
DSL
$1.14B
| $1.05M | 0.14% |
90,197
-2,736
| -3% | -$34.7K |
2024 Q4
1 quarter
|
|
166
John Hancock Premium Dividend Fund
PDT
$584M
| $1.05M | 0.14% |
84,646
-373
| -0.4% | -$4.78K |
2024 Q4
1 quarter
|
|
167
AT&T
T
$157B
| $1.04M | 0.14% |
38,383
-881
| -2% | -$22.2K |
2024 Q4
1 quarter
|
|
168
Sweetgreen
SG
$1.19B
| $1.04M | 0.13% |
+56,074
| New | +$1.55M |
2025 Q1
0 quarters
|
|
169
UnitedHealth
UNH
$339B
| $1.02M | 0.13% |
2,243
-286
| -11% | -$146K |
2024 Q4
1 quarter
|
|
170
iShares Core US Aggregate Bond ETF
AGG
$137B
| $1.02M | 0.13% |
10,391
-1,667
| -14% | -$163K |
2024 Q4
1 quarter
|
|
171
First Trust Institutional Preferred Securities and Income ETF
FPEI
$1.87B
| $1.02M | 0.13% |
55,648
+6,416
| +13% | +$120K |
2024 Q4
1 quarter
|
|
172
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.6B
| $1M | 0.13% |
19,926
-2,902
| -13% | -$147K |
2024 Q4
1 quarter
|
|
|
173
PIMCO Dynamic Income Fund
PDI
$6.73B
| $998K | 0.13% |
55,864
-136,896
| -71% | -$2.67M |
2024 Q4
1 quarter
|
|
174
Digital Realty Trust
DLR
$66.1B
| $994K | 0.13% |
6,594
+2,444
| +59% | +$398K |
2024 Q4
1 quarter
|
|
175
O'Reilly Automotive
ORLY
$69.6B
| $990K | 0.13% |
10,680
-105
| -1% | -$9.13K |
2024 Q4
1 quarter
|
|
Similar funds
TIM
AFCM
ACM
DIP
CS
B
LIA
WTA
Sovran Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Sovran Advisors held 481 positions worth $770M, up 9.8% from $702M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Sovran Advisors deployed $130M of net new capital in Q1 2025, opening 73 new positions and adding to 256 existing holdings. Its largest new stake was Novo Nordisk: 36,559 shares worth $2.12M.
By sector, the portfolio is most concentrated in Miscellaneous at 73% of assets, down from 75% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was PIMCO Dynamic Income Fund, an estimated $2.67M trimmed.
- Sovran Advisors's largest Q1 2025 buy was Novo Nordisk: 36,559 shares worth $2.12M.
- Sovran Advisors added most to Qualcomm in Q1 2025, an estimated $7.21M increase.
- Sovran Advisors's biggest Q1 2025 reduction was PIMCO Dynamic Income Fund, cutting an estimated $2.67M.
- Sovran Advisors fully exited Celldex Therapeutics in Q1 2025, selling an estimated $2.6M.
- Sovran Advisors's ten largest holdings make up 20% of its $770M portfolio in Q1 2025.
- Sovran Advisors opened 73 new positions and closed 26 in Q1 2025.
- Sovran Advisors's portfolio value rose 9.8% quarter-over-quarter to $770M.
Based on Sovran Advisors's 13F filing for Q1 2025, filed 25 Apr 2025.